Search Within

Sergio Andres Giralt

  1. "Health Outcomes Research Group"
Formats
  1. Meeting Abstract (3)
  2. Journal Article (2)
Groups
  1. Bone Marrow Transplant (5)
  2. Center for Hematologic Malignancies (5)
  3. Department of Medicine (5)
  4. Epidemiology and Biostatistics (5)
  5. Health Outcomes Research Group (5)
  6. Hematologic Malignancies, Division of (5)

More Groups

People
  1. Gunjan Shah (4)
  2. Jae Park (4)
  3. Maria Palomba (4)
  4. Miguel-Angel Perales (4)
  5. Peter Bach (4)
  6. Anas Younes (3)

More People

Years
  1. 2025 (1)
  2. 2019 (2)
  3. 2018 (1)
  4. 2017 (1)
Publications
  1. Biology of Blood and Marrow Transplantation (1)
  2. Blood (1)
  3. JAMA - Journal of the American Medical Association (1)
  4. Nature Medicine (1)
  5. Value in Health (1)
Publishers
  1. American Medical Association (1)
  2. American Society of Hematology (1)
  3. Elsevier Inc. (1)
  4. Elsevier Science, Inc. (1)
  5. Nature Publishing Group (1)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • An inflammatory biomarker signature of response to CAR-T cell therapy in non-Hodgkin lymphoma
    Journal Article

    Raj, S. S.; Fei, T.; Fried, S.; Ip, A.; Fein, J. A.; Leslie, L. A.; Alarcon Tomas, A.; Leithner, D.; Peled, J. U.; Corona, M.; more...
    Nature Medicine (2025)

    Fulltext@MSK | Save
  • Thirty day resource utilization after chimeric antigen receptor (CAR) T cell infusion for hematologic malignancies
    Meeting Abstract

    Shah, G. L.; Park, J.; Sauter, C. S.; Duck, E.; Halton, E.; Batlevi, C. W.; Palomba, M. L.; Younes, A.; Geyer, M. B.; Smith, E.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Resource utilization within 30 days of car T cells for hematologic malignancies
    Meeting Abstract

    Shah, G.; Park, J.; Sauter, C.; Duck, E.; Halton, E.; Batlevi, C.; Palomba, M. L.; Younes, A.; Geyer, M.; Smith, E.; more...
    Value in Health (2019)

    Fulltext@MSK | Save
  • Resource utilization early after chimeric antigen receptor (CAR) T cell infusion for hematologic malignancies
    Meeting Abstract

    Shah, G. L.; Park, J. H.; Sauter, C. S.; Duck, E.; Halton, E.; Palomba, M. L.; Batlevi, C. L.; Younes, A.; Geyer, M. B.; Smith, E. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • FDA approval of tisagenlecleucel: Promise and complexities of a $475 000 cancer drug
    Journal Article

    Bach, P. B.; Giralt, S. A.; Saltz, L. B.
    JAMA - Journal of the American Medical Association (2017)

    Fulltext@MSK | Save